FIG 5.
(A-J) Kaplan-Meier plots for overall survival for nine actionable genes commonly altered in clinical protocol patients (A-I) and for the most common cancer types represented in the protocol (J). No cancer type or alteration in a specific gene had a significant impact on patient survival. HN, head and neck.